Drug Information

Drug General Information
Drug ID
D0F4BX
Former ID
DNC000746
Drug Name
HU210
Drug Type
Small molecular drug
Indication Discovery agent Investigative [542332]
Structure
Download
2D MOL

3D MOL
Formula
C25H38O3
InChI
InChI=1S/C25H38O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h10,14-15,19-20,26-27H,6-9,11-13,16H2,1-5H3/t19-,20-/m1/s1
InChIKey
SSQJFGMEZBFMNV-WOJBJXKFSA-N
CAS Number
CAS 208265-92-3
PubChem Compound ID
9821569
PubChem Substance ID
14780496, 24124974, 24895815, 44857528, 47586752, 57373432, 76631031, 91704502, 103268592, 103961938, 113635243, 121369270, 134343244, 134367061, 135267030, 135650355, 142472553, 162226371, 164842208, 198962833, 227720043, 241182023, 241377549
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Agonist [535946]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 542332(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 731).
Ref 535946The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest. 2004 Apr;113(8):1202-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.